Verastem Inc (VSTM)
9.301
-0.31
(-3.22%)
USD |
NASDAQ |
Apr 24, 16:00
9.301
0.00 (0.00%)
After-Hours: 20:00
Verastem Enterprise Value: 146.16M for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 146.16M |
| April 22, 2024 | 149.45M |
| April 19, 2024 | 151.98M |
| April 18, 2024 | 161.85M |
| April 17, 2024 | 177.29M |
| April 16, 2024 | 179.57M |
| April 15, 2024 | 183.11M |
| April 12, 2024 | 188.93M |
| April 11, 2024 | 201.84M |
| April 10, 2024 | 188.93M |
| April 09, 2024 | 200.07M |
| April 08, 2024 | 203.11M |
| April 05, 2024 | 192.48M |
| April 04, 2024 | 189.69M |
| April 03, 2024 | 206.14M |
| April 02, 2024 | 194.50M |
| April 01, 2024 | 199.82M |
| March 28, 2024 | 201.59M |
| March 27, 2024 | 202.09M |
| March 26, 2024 | 196.27M |
| March 25, 2024 | 194.61M |
| March 22, 2024 | 207.51M |
| March 21, 2024 | 204.73M |
| March 20, 2024 | 201.19M |
| March 19, 2024 | 189.05M |
| Date | Value |
|---|---|
| March 18, 2024 | 171.60M |
| March 15, 2024 | 181.21M |
| March 14, 2024 | 168.56M |
| March 13, 2024 | 174.63M |
| March 12, 2024 | 177.01M |
| March 11, 2024 | 192.17M |
| March 08, 2024 | 195.46M |
| March 07, 2024 | 201.02M |
| March 06, 2024 | 223.78M |
| March 05, 2024 | 216.44M |
| March 04, 2024 | 223.78M |
| March 01, 2024 | 232.12M |
| February 29, 2024 | 217.96M |
| February 28, 2024 | 226.81M |
| February 27, 2024 | 234.65M |
| February 26, 2024 | 233.89M |
| February 23, 2024 | 224.03M |
| February 22, 2024 | 207.34M |
| February 21, 2024 | 214.67M |
| February 20, 2024 | 223.27M |
| February 16, 2024 | 217.71M |
| February 15, 2024 | 199.76M |
| February 14, 2024 | 202.79M |
| February 13, 2024 | 199.76M |
| February 12, 2024 | 202.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.29M
Minimum
Oct 20 2022
732.38M
Maximum
Jun 21 2021
182.85M
Average
151.98M
Median
Apr 19 2024
Enterprise Value Benchmarks
| Johnson & Johnson | 366.81B |
| Geron Corp | 1.659B |
| Altimmune Inc | 338.86M |
| Oragenics Inc | 3.306M |
| Actinium Pharmaceuticals Inc | 127.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.37M |
| Total Expenses (Quarterly) | 31.14M |
| EPS Diluted (Quarterly) | -1.03 |
| Earnings Yield | -44.19% |
| Normalized Earnings Yield | -52.90 |